About Schrödinger
Schrödinger is a company based in New York (United States) founded in 1990 by William A Goddard was acquired by Baron Funds in May 2020. It operates as a SaaS (Software-as-a-Service) and Professional Services. Schrödinger has raised $162 million across 10 funding rounds from investors including WuXi AppTec, Gates Foundation and HHS. The company has 891 employees as of December 31, 2024. Schrödinger offers products and services including Maestro, LiveDesign, MS Maestro, and FEP+. Schrödinger operates in a competitive market with competitors including Nimbus Therapeutics, PhaseCraft, Cradle, EvolutionaryScale and Evozyne, among others.
- Headquarter New York, United States
- Employees 891 as on 31 Dec, 2024
- Founders William A Goddard
- Stage Public
-
Sectors
Industrial Goods & ManufacturingHealthcare Technology
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Schrodinger, Inc.
-
Annual Revenue
$207.54 M (USD)-4.21as on Dec 31, 2024
-
Net Profit
-$187.12 M (USD)-559.54as on Dec 31, 2024
-
EBITDA
-$203.14 M (USD)-18.17as on Dec 31, 2024
-
Total Equity Funding
$162 M (USD)
in 10 rounds
-
Latest Funding Round
$4.9 M (USD), Grant
Nov 18, 2021
-
Investors
WuXi AppTec
& 11 more
-
Employee Count
891
as on Dec 31, 2024
-
Acquired by
Baron Funds
(May 18, 2020)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Schrödinger
Schrödinger is a publicly listed company on the NASDAQ with ticker symbol SDGR in USA, operating in the Technology services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Schrödinger
Schrödinger offers a comprehensive portfolio of products and services, including Maestro, LiveDesign, MS Maestro, and FEP+.
Software for molecular modeling in drug discovery research.
Platform for collaborative drug design and data management.
Tool for molecular modeling in materials science applications.
Software for free energy calculations in drug design.
People of Schrödinger
Unlock access to complete
Unlock access to complete
Funding Insights of Schrödinger
Schrödinger has successfully raised a total of $162M across 10 strategic funding rounds. The most recent funding activity was a Grant round of $4.9 million completed in November 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Schrödinger
Schrödinger has secured backing from 12 investors, including institutional, venture fund, and angel investors. Prominent investors backing the company include WuXi AppTec, Gates Foundation and HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Healthcare ecosystem is supported through investment and innovation by Deerfield.
|
Locked | Locked | Locked | |
|
Venture capital investments are directed toward multiple sectors.
|
Locked | Locked | Locked | |
|
Corporate backed venture capital fund investing in multiple sectors
|
Locked | Locked | Locked |
Investor details for Schrödinger
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Schrödinger
Investment portfolio details for Schrödinger
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Schrödinger
Detailed financials for Schrödinger
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Schrödinger Comparisons
Peer comparison for Schrödinger
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Schrödinger
Schrödinger operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Nimbus Therapeutics, PhaseCraft, Cradle, EvolutionaryScale and Evozyne, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Targeted therapeutics for cancer, metabolic, and inflammatory diseases are developed.
|
|
| Locked | Locked | Locked |
Quantum simulation systems are provided for materials and chemical reactions.
|
|
| Locked | Locked | Locked |
Chemoproteomics solutions are provided for protein design and development.
|
|
| Locked | Locked | Locked |
Provider of an AI models for protein design
|
|
| Locked | Locked | Locked |
Developer of proteins using protein engineering technology
|
|
| Locked | Locked | Locked |
An AI-based protein design platform is provided for drug discovery.
|
Detailed competitors of Schrödinger
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Schrödinger
Complete news archive for Schrödinger
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Schrödinger
Schrödinger was founded in 1990 and raised its 1st funding round 17 years after it was founded.
Schrödinger is headquartered in New York, United States. It is registered at New York, New York, United States.
Ramy Farid is the current CEO of Schrödinger.
Schrödinger is a funded company, having raised a total of $162M across 10 funding rounds to date.
As of Dec 31, 2024, the latest employee count at Schrödinger is 891.
Annual revenue of Schrödinger is $207.54M as on Dec 31, 2024.
Schrödinger is engaged in creating computational platforms powered by physics to transform therapeutics and materials discovery. The company operates in life sciences and materials science sectors, offering solutions for drug discovery, biologics, and advanced materials design. Key areas include small molecule discovery, antibody design, and polymeric materials. Software products like Maestro, LiveDesign, and FEP are provided alongside services for collaborative research. The company also advances a proprietary pipeline of therapeutics targeting high-value, validated targets. Educational resources and certification courses are offered to support digital chemistry adoption across industries.
Schrödinger's top competitors include Nimbus Therapeutics, Cradle and Profluent Bio.
Schrödinger offers Maestro, LiveDesign, MS Maestro, and FEP+.
Yes, Schrödinger is publicly traded on NASDAQ under the ticker symbol SDGR.
Schrödinger has 12 investors. Key investors include WuXi AppTec, Gates Foundation, HHS, European Union, and Qiming Venture Partners.
The ticker symbol of Schrödinger is SDGR on NASDAQ.